Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$104K Sell
494
-234
-32% -$50.2K ﹤0.01% 935
2026
Q1
$161K Buy
+728
New +$178K ﹤0.01% 781
2025
Q4
Sell
-743
Closed -$184K 1525
2025
Q3
$184K Buy
+743
New +$178K ﹤0.01% 644
2025
Q2
Sell
-826
Closed -$187K 1587
2025
Q1
$187K Sell
826
-11
-1% -$2.42K ﹤0.01% 610
2024
Q4
$172K Buy
837
+42
+5% +$9.21K ﹤0.01% 613
2024
Q3
$193K Buy
795
+32
+4% +$7.48K ﹤0.01% 585
2024
Q2
$172K Buy
763
+54
+8% +$11.7K ﹤0.01% 651
2024
Q1
$156K Buy
+709
New +$160K ﹤0.01% 588

Other funds holding STE

Mather Group's STE Position: Q2 2026 in Review

Mather Group reduced its Steris (STE) stake by 32% in Q2 2026, selling an estimated $50.2K and leaving 494 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #935.

Mather Group first reported a position in STE in Q1 2024 and has held it in 8 quarters since. The position peaked at $193K in Q3 2024. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Mather Group held 494 shares of Steris worth $104K as of Q2 2026.
  • Mather Group sold 234 Steris shares in Q2 2026, an estimated $50.2K.
  • Steris made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #935 holding.
  • Mather Group first reported a position in Steris in Q1 2024 and has held it in 8 quarters since.
  • Mather Group's Steris position peaked at $193K in Q3 2024.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.